文献速递慢性肾脏病肾血管病与高血压血液净化与透析

降压治疗早期肾小球滤过率下降与慢性肾脏病结局的挑战

The challenge of early glomerular filtration rate decline in response to antihypertensive treatment and chronic kidney disease outcomes.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

综述探讨高血压与慢性肾脏病(CKD)的关联,以及强化降压达标对心血管(CV)和肾脏结局的影响。重点分析血管紧张素转换酶抑制剂/血管紧张素受体拮抗剂或不同血压目标引起的早期肾小球滤过率(GFR)下降在肾脏和CV结局中的临床意义,并讨论如何据此决定继续或停用降压治疗。

要点

  • 强化降压对高CV风险患者有CV获益,但对CKD患者的肾脏影响尚不明确。
  • 降压治疗早期GFR下降是肾内科临床关注的问题,需结合肾脏和CV结局判断。
  • 早期GFR下降的临床意义需在ACEI/ARB或不同血压目标下评估,以指导治疗决策。

核心结论

  • 降压治疗早期GFR下降的临床意义需结合肾脏和CV结局综合评估,以决定继续或停用降压治疗。

研究设计与样本

  • 本文为综述,讨论近期随机对照试验的事后分析结果,聚焦高CV风险患者及CKD患者。

主要发现

  • 强化降压达标对高CV风险患者的CV疾病相关死亡率有有益影响。
  • 达标对肾功能的影响仍不明确,尤其对CKD患者。
  • 降压治疗早期GFR下降仍是肾内科临床实践中的顾虑。

临床怎么用

  • 临床中需评估ACEI/ARB或不同血压目标下早期GFR下降的意义,结合肾脏和CV结局权衡继续或停用降压治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hypertension and chronic kidney disease (CKD) are closely linked pathological processes. Combating high blood pressure (BP) is an essential part of preventing CKD progression and reducing cardiovascular (CV) risk. Data from recent randomized controlled trials on patients at high CV risk showed the beneficial effects of intensive action to meet BP targets on mortality related to CV disease. The impact of meeting such targets on renal function is still unclear, however, particularly for patients with CKD. This issue has been the object of several post hoc analyses because lowering BP definitely has a nephroprotective role, but the early decline in glomerular filtration rate (GFR) associated with antihypertensive therapies and strict BP targets is still a concern in nephrology clinical practice. The present review discusses the results of studies on this topic, focusing specifically on the clinical significance of early GFR decline in response to treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, or to different BP targets, in terms of renal and CV outcomes, and how this tips the balance towards continuing or discontinuing antihypertensive therapy.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Signorini L, Zaza G, Gambaro G, et al. The challenge of early glomerular filtration rate decline in response to antihypertensive treatment and chronic kidney disease outcomes. Nephrol Dial Transplant. 2022. PMID: 33155053. doi:10.1093/ndt/gfaa171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。